Drug-Induced Photosensitivity

Abstract

Get full access to this article

View all access options for this article.

References

Facts & Comparisons 4.0 [database online]. St. Louis, MO: Wolters Kluwer Health.

Frishman

W.H.

, Brosnan

B.D.

, Grossman M; Dasgupta

, Sun

A.D.

Adverse dermatologic effects of cardiovascular drug therapy: part I. Cardiol Rev. 2002; 10(4): 230–246.

Elias

S.S.

, Patel

N.M.

, Cheigh

N.H.

Drug-Induced Reactions. In: Pharmacotherapy; A Pathophysiologic Approach. 5th ed. McGraw-Hill, Ballantine, NY; 2002; 1708.

Cardizem LA [package insert]. Biovail Pharmaceuticals; 2004.

Taylor

C.R.

Photosensitivity: classification, diagnosis, and treatment. Dermatol Nurs. 1998; 10(5): 323–330.

Racette

A.J.

, Roenigk

H.H.

, Hansen

, Mendelson

, Park

Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl. J Am Acad Dermatol. 2005; 52(5 suppl): S81–S85.

Frishman

W.H.

, Brosnan

B.D.

, Grossman

, Dasgupta

, Sun

D.K.

Adverse dermatologic effects of cardiovascular drug therapy: part II. Cardiol Rev. 2002; 10(5): 285–300.

J-Tan [package insert]. Jaymac Pharmaceuticals; 2005.

Engin

, Oguz

Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses. Int J Dermatol. 2005; 44(4): 337–339.

10.

Chlorpheniramine [package insert]. Time-Cap Labs; 1998.

11.

Tolland

, Elborn

, McKenna

Ciprofloxacin-induced phototoxicity in patients with cystic fibrosis. J Am Acad Dermatol. 2005; 52(3)(suppl): 158.

12.

Clemastine [package insert]. Geneva Pharmaceuticals; 2001.

13.

Treudler

, Georgieva

, Geilen

C.C.

, Orfanos

C.E.

Dacarbazine but not temozolomide induces phototoxic dermatitis in patients with malignant melanoma. J Am Acad Dermatol. 2004; 50(5): 783–785.

14.

Dexchlorpheniramine [package insert]. Morton Grove Pharmaceuticals; 2002.

15.

Shah

, Warnakulasuriya

Amiodarone-induced peri-oral photosensitivity. J Oral Pathol Med. 2004; 33(1): 56–58.

16.

Croom

K.F.

, Goa

K.L.

Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. Drugs. 2003; 63(24): 2769–2802.

17.

Ricciardi

, Fedele

, Mazzeo

, Saitta

, Mancuso

, Isola

Adverse reactions to Pantoprazole.

Scand J Gastroenterol. 2003; 38(7): 800.

18.

Leone

, Venegoni

, Motola

. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regions. Drug Saf. 2003; 26(2): 109–120.

19.

Dawe

R.S.

, Ibbotson

S.H.

, Sanderson

J.B.

, Thompson

E.M.

, Ferguson

A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity. Br J Dermatol. 2003; 149(6): 1232–1241.

20.

Spironolactone: first report of photosensitivity: case report. Reactions Weekly. 2003; 937: 14.

21.

Hautmann

, Lotti

Psychoactive drugs and skin. J Eur Acad Dermatol Venereol. 2003; 17(4): 383–393.

22.

Lim

D.S.

, Murphy

G.M.

High-level ultraviolet A photoprotection is needed to prevent doxycycline phototoxicity: lessons learned in East Timor. Br J Dermatol. 2003; 149(1): 213–214.

23.

Morison

W.L.

Solar urticaria due to progesterone compounds in oral contraceptives. Photodermatol Photoimmunol Photomed. 2003; 19(3): 155–156.

24.

Cyproheptadine [package insert]. Pliva, Inc.; 2003.

25.

Lozol [package insert]. Aventis Pharmaceuticals; 2002.

26.

Flutamide [package insert]. Ivax Pharmaceuticals; 2002.

27.

Lim

D.S.

, Triscott

O'Brien's actinic granuloma in association with prolonged doxycycline phototoxicity. Australas J Dermatol. 2003; 44(1): 67–70.

28.

Moore

D.E.

Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf. 2002; 25(5): 345–372.

29.

Millard

T.P.

, Hawk

J.L.

Photosensitivity disorders: cause, effect and management. Am J Clin Dermatol. 2002; 3(4): 239–246.

30.

Azulfidine [package insert]. Pharmacia; 2002

31.

Selvaag

, Petersen

A.B.

, Gniadecki

, Thorn

, Wulf

H.C.

Phototoxicity to diuretics and antidiabetics in the cultured keratinocyte cell line HaCaT: evaluation by clonogenic assay and single cell gel electrophoresis (Comet Assay). Photodermatol Photoimmunol Photomed. 2002; 18(2): 90–95.

32.

Correia

, Lomba

V.H.

, Azevedo

, Delgado

, Polonia

Possible phototoxicity with subsequent progression to discoid lupus following pantoprazole administration. Clin Exp Dermatol. 2001; 26(5): 455–456.

33.

Bagheri

, Lhiaubet

, Montastruc

J.L.

, Chouini-Lalanne

Photosensitivity to ketoprofen: mechanisms and pharmacoepidemiological data. Drug Saf. 2000; 22(5): 339–349.

34.

George

Methylene-blue-induced hyperbilirubinemia and phototoxicity in a neonate. Clin Pediatr. 2000; 39(11): 659.

35.

Porat

, Gilbert

, Magilner

Methylene blue-induced phototoxicity: an unrecognized complication. Pediatrics. 1996; 97(5): 717–721.

36.

Moyer

D.B.

Continued treatment with fluorouracil for colon cancer despite severe phototoxic dermatitis. J Allerg Clin Immunol. 1996; 97(1, part 3): 341.

37.

McKenna

K.E.

, Stern

R.S.

Photosensitivity associated with combined UV-B and calcipotriene therapy. Arch Dermatol. 1995; 131(11): 1305–1307.

38.

Yoshimoto

, Konishi

, Takahashi

. The first case of efavirenz-induced photosensitivity in a Japanese patient with HIV infection. Intern Med. 2004; 43: 630–631.

39.

Cordarone [package Insert]. Wyeth Pharmaceuticals; 2004.

40.

Lipitor [package insert]. Pfizer; 2004.

41.

Lescol [package insert]. Novartis; 2003.

42.

Mevacor [package insert]. Merck & Co. Inc; 2005.

43.

Pravachol [package insert]. Bristol-Myers Squibb; 2004.

44.

Zocor [package insert]. Merck & Co. Inc; 2004.

45.

Crestor [package insert]. AstraZeneca; 2005.

46.

Sculptra [package insert]. Dermik Labs; 2004.

47.

Coreg [package insert]. GlaxoSmithKline; 2005.

48.

Lamictal [package insert]. GlaxoSmithKline; 2004.

49.

Topamax [package insert]. OrthoMcNeil Pharmaceutical Inc; 2000.

50.

Cozaar [package insert]. Merck & Co. Inc; 2004.

51.

Effexor [package insert]. Wyeth Pharmaceuticals; 2005.

52.

Gleevec [package insert]. Novartis; 2005.

53.

Photofrin [package insert]. Axcan Scandipharm Inc; 2003.

54.

Pentasa [package insert]. Shire US Inc; 2004.

55.

Factive [package insert]. Oscient Pharmaceuticals; August 2004.

56.

Zithromax [package insert]. Pfizer Labs; 2004.

57.

Vistide [package insert]. Gilead Sciences, Inc; 2000.

58.

Pyrazinamide [package insert]. Stada Pharmaceuticals, Inc; 2004.

59.

Quinidine Gluconate Inj [package insert]. Eli Lilly Co; 1999.

60.

Hydroxychloroquine Sulfate [package insert]. Mylan Pharmaceuticals, Inc; 2004.

61.

Felbatol [package insert]. Med-Pointe Pharmaceuticals; 2003.

62.

Doxycylcine Hyclate [package insert]. Mutual Pharmaceutical Co., Inc; 2004.

63.

Dacarbazine [package insert]. Faulding Pharmaceutical Co; 2002.

64.

Trecator [package insert]. Wyeth Pharmaceuticals; 2005.

65.

Diabinese [package insert]. Pfizer Labs; 2001.

66.

Cooper

S.M.

, George

Photosensitivity reaction associated with use of the combined oral contraceptive. Br J Dermatol. 2001; 144(3): 641–642.

67.

Zyrtec [package insert]. Pfizer Labs; 2004.

68.

Taylor

W.R.

, White

N.J.

Antimalarial drug toxicity: a review. Drug Saf. 2004; 27(1): 25–61.

69.

Martin-Garcia

R.F.

, del

, Camacho

, Sanchez

J.L.

Chloroquine-induced, vitiligo-like depigmentation. J Am Acad Dermatol. 2003; 48(6 part 1): 981–983.

70.

Viagra [package insert]. Pfizer Labs; 2005.

71.

Sporanox [package insert]. Abbott Laboratories, Inc; 2004.

72.

Terazol [package insert]. OrthoMcNeil Pharmaceutical Inc; 2001.

73.

Cutaneous drug reaction case reports: from the world literature. Am J Clin Dermatol. 2003; 4(11): 803–807.

74.

Minocycline HCl [package insert]. Par Pharmaceuticals, Inc; 2004.

75.

Trimethoprim [package insert]. Teva Pharmaceuticals, Inc; 2003.

76.

ProSom [package insert]. Abbott Laboratories, Inc; 2004.

77.

Mefenamic Acid [package insert]. First Horizon Pharmaceuticals Corporation; 2003.

78.

Phenergan [package insert]. Wyeth Pharmaceuticals, Inc; 2004.

79.

Norpramin [package insert]. Aventis Pharmaceuticals, Inc; 2005.

80.

Koppel

R.A.

, Boh

E.E.

Cutaneous reactions to chemotherapeutic agents. Am J Med Sci. 2001; 321(5): 327–335.

81.

Frye

C.B.

, Pettigrew

T.J.

Angioedema and photosensitive rash induced by valsartan. Pharmacotherapy. 1998; 18(4): 866–868.

82.

Frishman

W.H.

, Brosnan

B.D.

, Grossman

, Dasgupta

, Sun

D.K.

Adverse dermatologic effects of cardiovascular drug therapy: part III. Cardiol Rev. 2002; 10(6): 337–348.

83.

Diphenhydramine [package insert]. American Pharmaceutical Partner, Inc; 2002.

84.

Palgic [package insert]. Pamlab, LLC.; 2002.

85.

Phenergan [package insert]. Wyeth Pharmaceuticals; 2004.

86.

Sular [package insert]. First Horizon Pharmaceutical; 2004.

87.

Betapace [package insert]. Berlex Laboratories; 2003.

88.

Cytovene [package insert]. Roche; 2003.

89.

Eich

; Scharffetter-Kochanek

, Eich

H.T.

, Tantcheva-Poor

, Kreig

Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer. Am J Clin Oncol. 2002; 25(6): 599–602.

90.

Danazol [package insert]. Barr Laboratories; 1999.

91.

Tolazamide [package insert]. Mylan Pharmaceuticals; 2001.

92.

Requip [package insert]. Glaxo SmithKline; 2005.

93.

Gabitril [package insert]. Cephalon, Inc; 2001.

94.

Gentamicin [package insert]. Taro Pharmaceuticals; 2004.

95.

Flexeril [package insert]. McNeil Consumer; 2005.

96.

Surmontil [package insert]. Odyssey Pharmaceuticals; 2001.